Session 3: Post-approval pharmacogenomics: impact on Risk Management Plans and Information – Video




Session 3: Post-approval pharmacogenomics: impact on Risk Management Plans and Information
Speaker: Isabelle Moulon, Head of Sector for Medical information, EMA Workshop on Pharmacogenomics: from science to clinical care (8 October 2012)From:emainfoViews:0 0ratingsTime:10:23More inScience Technology

See the original post here:
Session 3: Post-approval pharmacogenomics: impact on Risk Management Plans and Information - Video

Related Posts

Comments are closed.